Gene therapy via nanoparticles reduces peritoneal fibrosis in mice

Gene therapies may reduce peritoneal fibrosis—a leading cause of PD failure. Delivering transforming growth factor using nanoparticles worked in a mouse study.

Read the abstract » | (added 05/09/2015)

Tags: